$9.72
+0.73%AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. is headquartered in Plymouth Meeting, Pennsylvania.
Chief Accounting Officer
Compensation
$602,741
Chief Commercial Officer
Chief Compliance Officer
Chief Executive Officer & Director
Compensation
$2,149,392
Chief Financial Officer
Compensation
$1,402,674
Chief Information Officer
Chief Legal Officer, General Counsel & Secretary
Chief Operating Officer
Compensation
$353,997
Chief People Officer
Chief Technology Officer
Compensation
$969,611
During the last 12 months, insiders have purchased $48.82M and sold $127K worth of AHCO shares, resulting in $48.69M of net buying activity.
5.0M
48.70M
0
0.00
+48.7M
+$48.70M
13.0K
116.23K
0
0.00
+116K
+$116K
0
0.00
5.0K
47.15K
-47K
-$47K
0
0.00
8.2K
79.79K
-80K
-$80K
Cashin Richard M Jr
10 Percent Owner
$24.35M
Oep Vii Gp, L.L.C.
10 Percent Owner
$24.35M
Wolf Dale B
Director
$72K
Rew Richard W. Ii
Officer: Clo And General Counsel
$45K
Williams David Solomon Iii
Director
$127K
Strong bullish signal with $48.69M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Exceptional buy/sell ratio. Buying dramatically outweighs selling—one of the strongest possible insider signals.
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
4 insider buyers vs. 1 sellers. Broad-based buying across management team suggests widespread confidence.
Strong confluence of bullish signals: High buy/sell ratio, multiple insiders participating, and recent buying momentum all point to significant insider confidence. This level of coordinated buying often precedes positive developments.
AHCO - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | June 18, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 30, 2025 | June 18, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 26, 2024 | June 20, 2024 | 2024 | |
DEF 14A DEF 14A N/A | May 01, 2023 | May 01, 2023 | ||
DEF 14A DEF 14A 2022 N/A | May 02, 2022 | June 22, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | July 06, 2021 | July 27, 2021 | 2021 | |
DEF 14A DEF 14A 2021 N/A | January 20, 2021 | March 03, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 29, 2020 | July 09, 2020 | 2020 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.